pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Vancomycin Hydrochloride
drug
save

vancomycin hydrochloride

Marketedupdated 3mo ago
by Samson Medical Technologies LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 5
  • tagApproval2 co-mentions · 1 sources
  • drugVancomycin Hydrochloride Viatris1 co-mentions · 1 sources
  • drugVanconal1 co-mentions · 1 sources
  • drugvancocin hydrochloride1 co-mentions · 1 sources
  • drugVancomycin Hydrochloride Pfizer1 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying vancomycin hydrochloride

  • phase2Abbreviated Protocol for Two-Stage Exchangecompletedn=76
  • phase2A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participantsrecruitingn=33

Patent cliff

source: FDA Orange Book
first barrier falls
Mar 13, 2035
~8.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (56)

  • Nov 6, 2035formulationUS 10039804
  • Nov 6, 2035formulationUS 10039804
  • Nov 6, 2035formulationUS 10039804
  • Nov 6, 2035formulationUS 10039804
  • Nov 6, 2035formulationUS 10039804
  • Nov 6, 2035formulationUS 10039804
  • Nov 6, 2035formulationUS 10039804
  • Nov 6, 2035formulationUS 10188697
  • Nov 6, 2035formulationUS 10188697
  • Nov 6, 2035formulationUS 10188697
  • Nov 6, 2035formulationUS 10188697
  • Nov 6, 2035formulationUS 10188697
  • Nov 6, 2035formulationUS 10188697
  • Nov 6, 2035formulationUS 10188697
  • Nov 6, 2035formulationUS 10849956
  • Nov 6, 2035formulationUS 10849956
  • Nov 6, 2035formulationUS 10849956
  • Nov 6, 2035formulationUS 10849956
  • Nov 6, 2035formulationUS 10849956
  • Nov 6, 2035formulationUS 10849956
  • Nov 6, 2035formulationUS 10849956
  • Nov 6, 2035method-of-use (U-282)US 11517609
  • Nov 6, 2035method-of-use (U-282)US 11517609
  • Nov 6, 2035method-of-use (U-282)US 11517609
  • Nov 6, 2035method-of-use (U-282)US 11517609
  • Nov 6, 2035method-of-use (U-282)US 11517609
  • Nov 6, 2035method-of-use (U-282)US 11517609
  • Nov 6, 2035method-of-use (U-282)US 11517609
  • Nov 6, 2035formulationUS 11628200
  • Nov 6, 2035formulationUS 11628200
  • Nov 6, 2035formulationUS 11628200
  • Nov 6, 2035formulationUS 11628200
  • Nov 6, 2035formulationUS 11628200
  • Nov 6, 2035formulationUS 11628200
  • Nov 6, 2035formulationUS 11628200
  • Nov 6, 2035formulationUS 12161690
  • Nov 6, 2035formulationUS 12161690
  • Nov 6, 2035formulationUS 12161690
  • Nov 6, 2035formulationUS 12161690
  • Nov 6, 2035formulationUS 12161690
  • Nov 6, 2035formulationUS 12161690
  • Nov 6, 2035formulationUS 12161690
  • Mar 13, 2035formulationUS 10493028
  • Mar 13, 2035formulationUS 10493028
  • Mar 13, 2035formulationUS 10688046
  • Mar 13, 2035formulationUS 10688046
  • Mar 13, 2035formulationUS 10959946
  • Mar 13, 2035formulationUS 10959946
  • Mar 13, 2035formulationUS 10959947
  • Mar 13, 2035formulationUS 10959947
  • Mar 13, 2035formulationUS 10959948
  • Mar 13, 2035formulationUS 10959948
  • Mar 13, 2035formulationUS 10959949
  • Mar 13, 2035formulationUS 10959949
  • Mar 13, 2035formulationUS 11638692
  • Mar 13, 2035formulationUS 11638692

News(0)

no news has mentioned this drug yet

brand
Vancomycin Hydrochloride
generic
vancomycin hydrochloride
indication
Bacterial Endocarditis
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?